Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6

Clinical trial NCT01329978 · COMPLETED

Trial details

NCT number: NCT01329978
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2011-03-01
Primary completion: 2012-08-01
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.